Anti-IL23A重组抗体|科研级 Tildrakizumab ( 替曲吉珠单抗 )-重组抗体试剂-泰克生物-酵母展示服务专家

Anti-IL23A重组抗体|科研级 Tildrakizumab ( 替曲吉珠单抗 )

详细相关信息靶点背景信息实验方案&FAQ 相关产品推荐服务

询价与订购

姓名*
电话号码*
电子邮件*
产品名称*
描述*

Anti-IL23A重组抗体|科研级 Tildrakizumab ( 替曲吉珠单抗 )

说明书联系我们

< >

详细相关信息

靶点背景信息

实验方案&FAQ

Catalog Number

TKYR1295

Alias

科研级 Tildrakizumab ( 替曲吉珠单抗 ), Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab

Molecular Name

Tildrakizumab

Size

1mg, 5mg

CAS Number

1326244-10-3

Isotype

IgG1 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

144.4 kDa

Applications

Neut, ELISA, IF, IP, FuncS, FC, ICC

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6426H9918N1698O2000S46

Target

IL23A[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

靶点背景信息

实验方案&FAQ